Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Margaritis Avgeris & Andreas Scorilas. (2016) Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies. Expert Opinion on Therapeutic Targets 20:7, pages 801-818.
Read now
Read now
Vittore Cereda, Vincenzo Formica, Antonello Menghi, Stefania Pellicori & Mario Roselli. (2015) Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges. Expert Opinion on Investigational Drugs 24:7, pages 929-947.
Read now
Read now
Andreas Scorilas & Konstantinos Mavridis. (2014) Predictions for the future of kallikrein-related peptidases in molecular diagnostics. Expert Review of Molecular Diagnostics 14:6, pages 713-722.
Read now
Read now
Articles from other publishers (20)
Srilakshmi Srinivasan, Thomas Kryza, Jyotsna Batra & Judith Clements. (2022) Remodelling of the tumour microenvironment by the kallikrein-related peptidases. Nature Reviews Cancer 22:4, pages 223-238.
Crossref
Crossref
Heike Thiemeyer, Leila Taher, Jan Torben Schille, Eva-Maria Packeiser, Lisa K. Harder, Marion Hewicker-Trautwein, Bertram Brenig, Ekkehard Schütz, Julia Beck, Ingo Nolte & Hugo Murua Escobar. (2021) An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes. International Journal of Molecular Sciences 22:21, pages 11481.
Crossref
Crossref
Mi Li, Jaroslav Srp, Michael Mareš, Alexander Wlodawer & Alla Gustchina. (2021) Structural studies of complexes of kallikrein 4 with wild-type and mutated forms of the Kunitz-type inhibitor BbKI. Acta Crystallographica Section D Structural Biology 77:8, pages 1084-1098.
Crossref
Crossref
Peng Xu & Mingdong Huang. (2020) Small Peptides as Modulators of Serine Proteases. Current Medicinal Chemistry 27:22, pages 3686-3705.
Crossref
Crossref
Zihao He, Xiaolu Duan & Guohua Zeng. (2019) Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods. PeerJ 7, pages e7872.
Crossref
Crossref
Afshin Moradi, Srilakshmi Srinivasan, Judith Clements & Jyotsna Batra. (2019) Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment. Cancer and Metastasis Reviews 38:3, pages 333-346.
Crossref
Crossref
Mi Li, Jaroslav Srp, Alla Gustchina, Zbigniew Dauter, Michael Mares & Alexander Wlodawer. (2019)
Crystal structures of the complex of a kallikrein inhibitor from
Bauhinia bauhinioides
with trypsin and modeling of kallikrein complexes
. Acta Crystallographica Section D Structural Biology 75:1, pages 56-69.
Crossref
Crossref
Panagiotis G. Adamopoulos, Panagiotis Tsiakanikas & Andreas Scorilas. (2018) Kallikrein-related peptidases and associated microRNAs as promising prognostic biomarkers in gastrointestinal malignancies. Biological Chemistry 399:8, pages 821-836.
Crossref
Crossref
Blake T. Riley, Olga Ilyichova, Jonathan M. Harris, David E. Hoke & Ashley M. Buckle. 2018. Extracellular Targeting of Cell Signaling in Cancer. Extracellular Targeting of Cell Signaling in Cancer
277
306
.
Iraklis K. Kyriakou, Konstantinos Mavridis, Despina P. Kalogianni, Theodore K. Christopoulos, Penelope C. Ioannou & Andreas Scorilas. (2017) Multianalyte quantitative competitive PCR on optically encoded microspheres for an eight-gene panel related to prostate cancer. Analytical and Bioanalytical Chemistry 410:3, pages 971-980.
Crossref
Crossref
Panagiotis G. Adamopoulos, Christos K. Kontos & Andreas Scorilas. (2017) Identification and molecular cloning of novel transcripts of the human kallikrein-related peptidase 10 ( KLK10 ) gene using next-generation sequencing. Biochemical and Biophysical Research Communications 487:4, pages 776-781.
Crossref
Crossref
Theodoros Tokas, Margaritis Avgeris, Christos Alamanis, Andreas Scorilas, Konstantinos G. Stravodimos & Constantinos A. Constantinides. (2016) Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients’ prognosis. Journal of Cancer Research and Clinical Oncology 143:3, pages 521-532.
Crossref
Crossref
Salvatore V. Pizzo, Roger L. Lundblad & Monte S. Willis. 2016. Proteolysis in the Interstitial Space. Proteolysis in the Interstitial Space
151
182
.
Lucas V.B. Hoelz, Bruna C. Zorzanelli, Pedro Henrique R.de A. Azevedo, Silvia G. Passos, Lucas R. de Souza, Marcelo Zani, Sergio Pinheiro, Luciano Puzer, Luiza R.S. Dias & Estela M.F. Muri. (2016) Synthesis, biological evaluation and molecular modeling of pseudo-peptides based statine as inhibitors for human tissue kallikrein 5. European Journal of Medicinal Chemistry 112, pages 39-47.
Crossref
Crossref
Magdalena Kalinska, Ulf Meyer-Hoffert, Tomasz Kantyka & Jan Potempa. (2016) Kallikreins – The melting pot of activity and function. Biochimie 122, pages 270-282.
Crossref
Crossref
Trisha A. Rettig, Julie N. Harbin, Adelaide Harrington, Leonie Dohmen & Sherry D. Fleming. (2015) Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer. Clinical Immunology 160:2, pages 244-254.
Crossref
Crossref
Kleita Michaelidou, Alexandros Ardavanis & Andreas Scorilas. (2015) Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival. Breast Cancer Research and Treatment 152:2, pages 323-336.
Crossref
Crossref
Kleita Michaelidou, Athina Kladi-Skandali & Andreas Scorilas. 2015. Biomarkers in Cancer. Biomarkers in Cancer
135
165
.
Margaritis Avgeris, Konstantinos Stravodimos & Andreas Scorilas. (2014)
Loss of miR-378 in prostate cancer, a common regulator of
KLK2
and
KLK4
, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients
. Biological Chemistry 395:9, pages 1095-1104.
Crossref
Crossref
Kleita Michaelidou, Athina Kladi-Skandali & Andreas Scorilas. 2014. Biomarkers in Cancer. Biomarkers in Cancer
1
25
.